Clinical Significance of Tumor Deposits in Gastric Cancer: a Retrospective and Propensity Score-Matched Study at Two Institutions

  • Lihu Gu
  • Ping Chen
  • Hui Su
  • Xinlong Li
  • Hepan Zhu
  • Xianfa Wang
  • Parikshit Asutosh Khadaroo
  • Danyi Mao
  • Manman ChenEmail author
Original Article



Gastric cancer (GC) treatment is largely determined by tumor stage. Despite improvements in the mode of treatment of various types of advanced disease, staging is still evolving. The role of tumor deposits (TDs) in staging remains debated. The purpose of this research is to investigate the relationship between TDs and prognosis in GC.


A total of 3098 patients were considered eligible for prognostic analysis (2706 patients in the TDs-negative group and 392 patients in the TDs-positive group). A one-to-one propensity score-matching analysis was performed using a logistic regression mode and the following covariates: age, gender, tumor location, size, differentiation, perineural invasion, lymphovascular invasion, pTNM stage, type of gastrectomy, and the number of lymph nodes retrieved between TDs-negative and TDs-positive group, then 323 patients in each group were analyzed. Univariate and multivariate analyses of prognostic factors were conducted accordingly. The predictive ability of different staging system incorporating TDs was evaluated.


TDs were present in 14.5% cases and almost all of the patients (99%) suffered from advanced GC. Multivariate analysis showed that pN stage, chemotherapy, and TDs were the independent prognostic factors. The TDs-positive group showed a lower rate of 5-year disease-free survival compared with the TDs-negative group in all patients, stage II, and stage III patients (p = 0.001, 0.029, and 0.003, respectively). The 5-year disease-free survival for patients with TDs and without TDs was 27.6% and 34.4%, respectively.


Our research shows that TDs are closely associated with prognosis in GC. TDs should be incorporated into the TNM staging system, which could then accurately improve the staging reliability and prognostic assessment.


Gastric cancer Tumor deposits Prognosis Tumor staging system 


Author Contributions

Manman Chen contributed to drafting, conception, and design; Lihu Gu, Ping Chen, and Hui Su contributed to manuscript writing; Lihu Gu, Xinlong Li, Hepan Zhu, and Xianfa Wang contributed to data collection; Parikshit Asutosh Khadaroo and Danyi Mao performed procedures and data analysis; All authors helped to perform the research.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Supplementary material

11605_2019_4421_Fig4_ESM.png (2.5 mb)
Supplementary Fig. 1

Morphologic patterns of perigastric TD (hematoxylin and eosin staining, x40). (PNG 2570 kb)

11605_2019_4421_MOESM1_ESM.tif (22.9 mb)
High Resolution Image (TIF 23459 kb)
11605_2019_4421_Fig5_ESM.png (172 kb)
Supplementary Fig. 2

Kaplan-Meier plot of 5-year disease-free survival (DFS) according to TNM staging system. A scheme A by Sun et al. P < 0.001, chi-square = 52.050; B scheme B by Chen et al. P < 0.001, chi-square = 67.096; C scheme C by us. P < 0.001, chi-square = 63.098; D AJCC TNM 8th. P < 0.001, chi-square = 52.137. (PNG 172 kb)

11605_2019_4421_MOESM2_ESM.tif (3.3 mb)
High Resolution Image (TIF 3413 kb)
11605_2019_4421_MOESM3_ESM.docx (21 kb)
Supplementary Table 1 (DOCX 21 kb)


  1. 1.
    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68(6):394-424.Google Scholar
  2. 2.
    Ajani JA, D’Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, et al. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(10):1286-312.CrossRefGoogle Scholar
  3. 3.
    Ueno H, Mochizuki H, Shirouzu K, Kusumi T, Yamada K, Ikegami M, et al. Multicenter study for optimal categorization of extramural tumor deposits for colorectal cancer staging. Annals of surgery. 2012;255(4):739-46.CrossRefGoogle Scholar
  4. 4.
    von Winterfeld M, Hoffmeister M, Ingold-Heppner B, Jansen L, Tao S, Herpel E, et al. Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition. European journal of cancer (Oxford, England : 1990). 2014;50(17):2958-65.CrossRefGoogle Scholar
  5. 5.
    Etoh T, Sasako M, Ishikawa K, Katai H, Sano T, Shimoda T. Extranodal metastasis is an indicator of poor prognosis in patients with gastric carcinoma. The British journal of surgery. 2006;93(3):369-73.CrossRefGoogle Scholar
  6. 6.
    Yildiz B, Etiz D, Dal P, Junushova B, Pasaoglu O, Yilmaz E, et al. Tumor deposits: Prognostic significance in gastric cancer patients. Journal of BUON : official journal of the Balkan Union of Oncology. 2016;21(6):1476-81.Google Scholar
  7. 7.
    Japanese classification of gastric carcinoma: 3rd English edition. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2011;14(2):101-12.Google Scholar
  8. 8.
    Yagi R, Shimada Y, Kameyama H, Tajima Y, Okamura T, Sakata J, et al. Clinical Significance of Extramural Tumor Deposits in the Lateral Pelvic Lymph Node Area in Low Rectal Cancer: A Retrospective Study at Two Institutions. Annals of surgical oncology. 2016;23(Suppl 4):552-8.CrossRefGoogle Scholar
  9. 9.
    Yamano T, Semba S, Noda M, Yoshimura M, Kobayashi M, Hamanaka M, et al. Prognostic significance of classified extramural tumor deposits and extracapsular lymph node invasion in T3-4 colorectal cancer: a retrospective single-center study. BMC cancer. 2015;15:859.CrossRefGoogle Scholar
  10. 10.
    Hamy AS, Pierga JY, Sabaila A, Laas E, Bonsang-Kitzis H, Laurent C, et al. Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2017;28(9):2233-40.CrossRefGoogle Scholar
  11. 11.
    Graham Martinez C, Knijn N. Tumour Deposits are a Significant Prognostic Factor in Gastric Cancer-A Systematic Review and Meta-Analysis. 2018.Google Scholar
  12. 12.
    Anup S, Lu J, Zheng CH, Li P, Xie JW, Wang JB, et al. Prognostic significance of perigastric tumor deposits in patients with primary gastric cancer. BMC surgery. 2017;17(1):84.CrossRefGoogle Scholar
  13. 13.
    Lee HS, Lee HE, Yang HK, Kim WH. Perigastric tumor deposits in primary gastric cancer: implications for patient prognosis and staging. Annals of surgical oncology. 2013;20(5):1604-13.CrossRefGoogle Scholar
  14. 14.
    Sun Z, Wang ZN, Xu YY, Zhu GL, Huang BJ, Xu Y, et al. Prognostic significance of tumor deposits in gastric cancer patients who underwent radical surgery. Surgery. 2012;151(6):871-81.CrossRefGoogle Scholar
  15. 15.
    Chen H, Tang Z, Chen L, Li H, Wang X, Liu F, et al. Evaluation of the impact of tumor deposits on prognosis in gastric cancer and a proposal for their incorporation into the AJCC staging system. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2018;44(12):1990-6.CrossRefGoogle Scholar
  16. 16.
    Nagtegaal ID, Knijn N, Hugen N, Marshall HC, Sugihara K, Tot T, et al. Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017;35(10):1119-27.CrossRefGoogle Scholar
  17. 17.
    Li X, An B, Zhao Q, Qi J, Wang W, Zhang D, et al. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China. International journal of surgery (London, England). 2018;56:188-94.CrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2019

Authors and Affiliations

  1. 1.Department of General Surgery, HwaMei HospitalUniversity of Chinese Academy of SciencesNingboChina
  2. 2.Department of General SurgeryZhejiang University School of Medicine Sir Run Run Shaw HospitalHangzhouChina
  3. 3.Monash University School of Public Health and Preventive MedicineMelbourneAustralia
  4. 4.Zhejiang Chinese Medical UniversityZhejiangChina
  5. 5.Affiliated Hospital of Medical School Ningbo University and Ningbo City Third HospitalNingboChina

Personalised recommendations